Retinal cases & brief reports · 2026
Nivolumab-induced hypoalbuminemia causing serous retinal detachment.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kraker Jessica A, Reddy Amit K, de Carlo Forest Talisa E
Аннотация
PURPOSE: To report a case of nivolumab induced hypoalbuminemia causing a serous retinal detachment.
METHODS: Multimodal imaging including optical coherence tomography, fundus photography, and fluorescein angiography was performed.
RESULTS: A 59-year-old female with a history of metastatic renal cell carcinoma on nivolumab/ipilimumab immunotherapy with a recent hospitalization for anasarca, ascites, pleural effusion, and hypotension developed bilateral chemosis and a serous retinal detachment in the right eye. There were no pachychoroid vessels, intraocular inflammation, or leakage on fluorescein angiography to suggest central serous chorioretinopathy or a Vogt-Koyanagi-Harada-like reaction to immunotherapy. The third spacing and hypoalbuminemia was thought to be due to nivolumab-induced capillary leak syndrome, and the offending medication was stopped. The conjunctival chemosis and subretinal fluid improved with correction of underlying systemic hypoalbuminemia.
CONCLUSION: This case highlights a case of nivolumab-induced hypoalbuminemia causing a serous retinal detachment. This serves as an excellent teaching case as the authors discuss pertinent clinical exam and multimodal imaging features that allow differentiation of serous retinal detachments due to medications, central serous chorioretinopathy, and Vogt-Koyanagi-Harada syndrome.
METHODS: Multimodal imaging including optical coherence tomography, fundus photography, and fluorescein angiography was performed.
RESULTS: A 59-year-old female with a history of metastatic renal cell carcinoma on nivolumab/ipilimumab immunotherapy with a recent hospitalization for anasarca, ascites, pleural effusion, and hypotension developed bilateral chemosis and a serous retinal detachment in the right eye. There were no pachychoroid vessels, intraocular inflammation, or leakage on fluorescein angiography to suggest central serous chorioretinopathy or a Vogt-Koyanagi-Harada-like reaction to immunotherapy. The third spacing and hypoalbuminemia was thought to be due to nivolumab-induced capillary leak syndrome, and the offending medication was stopped. The conjunctival chemosis and subretinal fluid improved with correction of underlying systemic hypoalbuminemia.
CONCLUSION: This case highlights a case of nivolumab-induced hypoalbuminemia causing a serous retinal detachment. This serves as an excellent teaching case as the authors discuss pertinent clinical exam and multimodal imaging features that allow differentiation of serous retinal detachments due to medications, central serous chorioretinopathy, and Vogt-Koyanagi-Harada syndrome.